Reduce Costs with Rep-less Model Strategic Purchasing


According to Edward Deming, uncontrolled variation is the enemy of quality and quite a bit of uncontrolled variation exists in today's medical device field. There are several ways to approach strategic contracting and partnerships in the health care supply chain arena. One option is using dis-intermediation, or a rep-less model, for medical device purchases. In this AHRMM on-demand webinar, the current standard for medical device sales and the opportunity for innovation in this space is discussed. We’ll review a strategic approach to the seven objections, from physicians and the c-suite, and then move into preparing a business case for this model. Results from a pilot project will be shared along with the critical success factors for implementing a rep-less model.